Target intelligence / Profile preview

RNA, U6 small nuclear 363, pseudogene (RNU6-363P)

Target
RNU6-363P
Molecular classification
Other (Pseudogene, non-coding RNA pseudogene)
01

Overview

RNU6-363P is a pseudogene copy of the U6 small nuclear RNA gene. U6 snRNA itself is an essential component of the spliceosome, the cellular machinery that removes introns from pre-mRNA[3][5]. Pseudogenes like RNU6-363P are DNA sequences similar to known genes but are typically nonfunctional due to mutations, lack of regulatory elements, or because they are not transcribed into functional RNA or protein. Though some pseudogenes can act as regulatory elements (such as miRNA decoys or competitive endogenous RNAs)[4], there is no current evidence that RNU6-363P has such a role. Additionally, "RNA, U6 small nuclear 363, pseudogene" is not a drug target or a molecule with direct cellular or pharmacological action, and therefore does not fall into conventional molecular classifications used for therapeutic targets such as "receptor," "enzyme," or "transport." This entry is primarily notable as a non-functional genomic element, and is not considered a receptor or other functional molecular target in drug discovery or therapeutic contexts, hence is_incorrect: true for purposes of most molecular targeting databases.

Other names
RNU6-363P
02

Biological functions

No direct biological function; pseudogenes typically lack coding or regulatory function, though some may have regulatory roles as competitive endogenous RNAs or miRNA decoys in rare cases
03

Disease associations

No documented disease role specific to RNU6-363P; most pseudogenes, including U6-derived, are not implicated directly in disease, though other pseudogenes can regulate gene expression in cancer and other pathologies

Beyond the preview

Go deeper on RNA, U6 small nuclear 363, pseudogene (RNU6-363P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 363, pseudogene (RNU6-363P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call